Jim Simons' Top Holdings: Analysis of Apple, Palantir, and Key Tech Stocks in Renaissance Technologies Portfolio (Q1 2026)

Renaissance Technologies' Jim Simons held significant stakes in top-performing companies like Apple and Palantir as of March 31, 2026, with notable shifts in holdings across sectors.

By AI Generated.May 15, 2026, 6:06 AM
Jim Simons' Top Holdings: Analysis of Apple, Palantir, and Key Tech Stocks in Renaissance Technologies Portfolio (Q1 2026)

As of March 31, 2026, Renaissance Technologies LLC, the highly successful quant hedge fund led by investor Jim Simons, held a diverse portfolio with a total value of approximately $61.8 billion. While the fund's strategies focus on mathematical models rather than fundamental analysis, its holdings reflect exposure to high-growth sectors, particularly Technology. This analysis examines the top ten holdings from Jim Simons' portfolio, highlighting significant allocations and changes in share positions.

Apple Inc. (AAPL) remains a cornerstone of the portfolio, with Jim Simons holding over 3 million shares valued at nearly $780 million. This allocation represents 1.22% of the total portfolio. Notably, the position saw a massive increase of over 983,000 shares (a 98.32% jump) during the period, reflecting either a strategic accumulation or a significant rise in the stock price, or both. Investors can explore Apple's performance and filings at AAPL.

Technology continues to dominate Simons' top holdings, with Palantir Technologies Inc. (PLTR) and Micron Technology Inc. (MU) also featuring prominently. The stake in PLTR, valued at around $1.0 billion (1.6% allocation), showed a significant reduction, with a decrease of over 1.8 million shares (-20.58%). Micron's position, worth approximately $730 million (1.14% allocation), also experienced a sharp decline, with nearly 850,000 shares (-28.17%) sold during the period. Further Technology holdings include VeriSign Inc. (VRSN) and NVIDIA Corporation (NVDA), both showing moderate increases in shares held by Renaissance Technologies.

Healthcare allocations include United Therapeutics Corp. (UTHR) and Exelixis Inc. (EXEL). UTHR, valued at nearly $1.0 billion (1.66% allocation), saw a modest reduction in shares (-6.4%). Exelixis' position, worth about $589 million (0.92% allocation), also experienced a slight decrease (-1.34%). Basic Materials exposure is present through Kinross Gold Corp. (KGC) and Franco Nev Corp. (FNV). KGC, valued at $780 million (1.22% allocation), saw a small increase in shares, while FNV's position, worth $548 million (0.86% allocation), decreased slightly (-10.46%). Sandisk Corp. (SNDK), with a null sector listed, holds a position valued at nearly $508 million (0.79% allocation) with a significant reduction in shares (-33.87%).

The data from March 31, 2026, provides insight into the dynamic nature of Renaissance Technologies' portfolio. The substantial increase in Apple shares contrasts sharply with the significant reductions seen in Palantir and Micron, suggesting a complex strategy that may involve timing the market or responding to fundamental shifts in these companies' prospects. For a complete overview of Jim Simons' investment profile, visit Renaissance Technologies LLC.